Acteoside relieves diabetic retinopathy through the inhibition of Müller cell reactive hyperplasia by regulating TXNIP and mediating Kir4.1 channels in a PI3K/Akt-dependent manner
2024

Acteoside Helps Treat Diabetic Retinopathy by Reducing Müller Cell Overgrowth

publication 10 minutes Evidence: high

Author Information

Author(s): Xi Xiaoting, Liu Xiaolei, Chen Qianbo, Ma Jia, Wang Xuewei, Gui Yufei, Zhang Yuxin, Li Yan

Primary Institution: The First Affiliated Hospital of Kunming Medical University, Kunming, China

Hypothesis

ACT is able to alleviate the progression of DR by inhibiting the reactive proliferation of Müller cells via the Kir4.1 channel.

Conclusion

ACT inhibits Müller cell reactive proliferation and alleviates diabetic retinopathy by regulating TXNIP and mediating the expression of Kir4.1 channels in a PI3K/Akt-dependent manner.

Supporting Evidence

  • ACT treatment improved retinal structure and reduced hemangiomas in diabetic rats.
  • TXNIP expression was significantly upregulated in diabetic retinopathy models.
  • ACT treatment inhibited the proliferation and migration of Müller cells.

Takeaway

This study shows that a natural compound called acteoside can help treat a serious eye problem caused by diabetes by stopping certain cells in the eye from growing too much.

Methodology

The study involved cell culture experiments with Müller RMC-1 cells and animal models of diabetic retinopathy, using various treatments and assays to measure cell proliferation, migration, and protein expression.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0312565

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication